Dr. Ezequiel Rodríguez Gullello

• 2010-2015 Programa de Doctorado en Medicina. Línea de investigación: Hígado, sistema digestivo y metabolismo. Director y tutor de tesis: Prof. Pere Ginès i Gibert. Universidad de Barcelona. Barcelona, España.
• 2010-2014 Fellowship en Hepatología.Línea de investigación: Cirrosis, ascitis y disfunción renal. Jefe: Prof. Pere Ginès i Gibert. Servicio de Hepatología Hospital Clinic de Barcelona. Universidad de Barcelona. Barcelona, España.
• 2010-2014 CANONIC Study Investigator. EASL-CLIF Consortium (European Association for the Study of the Liver - Chronic Liver Failure Consortium) Chairman of the European Chronic Liver Failure Consortium: Prof. Vicente Arroyo.

-Effects of alfapump system on kidney and circulatory function in patients with cirrhosis and refractory ascites. Solà E, Sanchez-Cabús S, Rodriguez E, Elia C, Cela R, Moreira R, Pose E, Sánchez-Delgado J, Cañete N, Morales-Ruiz M, Campos F, Balust J, Guevara M, García-Valdecasas JC, Ginès P. Liver Transpl. 2017 May;23(5):583-593. doi: 10.1002/lt.24763.

-Treatment of type-2 hepatorenal syndrome in patients awaiting transplantation. Effects on kidney function and transplantation outcomes. Rodríguez E, Pereira G, Solà E, Elia C, Barreto R, Pose E, Colmenero J, Fernández J, Navasa M, Arroyo V, Ginès P. Liver Transpl. 2015 Nov;21(11):1347-54.

-Analysis of a Urinary Biomarker Panel for Clinical Outcomes Assessment in Cirrhosis. Ariza X, Solà E, Elia C, Barreto R, Moreira R, Morales-Ruiz M, Graupera I, Rodríguez E, Huelin P, Solé C, Fernández J, Jiménez W, Arroyo V, Ginès P. PLoSOne 2015 Jun 4;10(6):e0128145.

-Reply to: "A cut-off serum creatinine value of 1.5mg/dl for AKI - To be or not to be" Fagundes C, Barreto R, Rodríguez E, Graupera I, Poch E, Solà E, Fernández J, Ginès P. J Hepatol. 2015 Mar 62 (3) 743–744

-Transient Increase in Urine Protein Excretion during Treatment with Terlipressin and Albumin for Type-1 Hepatorenal Syndrome. Elia C, Solà Verges E, Rodríguez E, Ginès P. J Hepatol. 2015 Feb, 62 (2) 493–495
-Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study. Cárdenas A, Solà E, Rodríguez E, Barreto R, Graupera I, Pavesi M, Saliba F, Welzel T, Martinez-Gonzalez J, Gustot T, Bernardi M, Arroyo V, Ginès P; CANONIC study investigators of the EASL-CLIF Consortium. Crit Care. 2014 Dec 13;18(6):700.
-Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Ginès P, Levesque E, Durand F, Angeli P, Caraceni P, Hopf C, Alessandria C, Rodríguez E, Solis-Muñoz P, Laleman W, Trebicka J, Zeuzem S, Gustot T, Mookerjee R, Elkrief L, Soriano G, Cordoba J, Morando F, Gerbes A, Agarwal B, Samuel D, Bernardi M, Arroyo V; CANONIC study investigators of the EASL-CLIF Consortium. J Hepatol. 2014 Nov; 61(5):1038-47.

-Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis. Angeli P, Rodríguez E, Piano S, Ariza X, Morando F, Solà E, Romano A, García E, Pavesi M, Risso A, Gerbes A, Willars C, Bernardi M, Arroyo V, Ginès P; CANONIC Study Investigators of the EASL-CLIF Consortium. Gut. 2014 Oct;64(10):1616-22.

-P Huelin, E Rodríguez, M Poca, M Martin-Llahi, C Elia, R Moreira, C Solè, I Cirera, J Sánchez, V Vargas, G Soriano, V Arroyo, E Sola, Pere Gines. Treatment of type 1 hepatorenal syndrome with terlipressin infusion adjusted according to hemodynamic response. the AMELIORATE study.50 th Annual Meeting of the European Association for the Study of the Liver. Vienna, Austria. 2015.

-E Rodríguez; C Elia; E Sola; R Barreto; I Graupera; A Andrealli; G Pereira; M Poca; J Sanchez; M Guevara; G Soriano; C Alessandria; J Fernández; V Arroyo; P Gines. Terlipressin and Albumin for Type-1 Hepatorenal Syndrome associated with Sepsis. Journal of Hepatology 2014 vol. 60 | S361–S522. 49 th Annual Meeting of the European Association for the Study of the Liver. London, United Kingdom. 2014.

-E. Rodríguez, C. Elia, E. Solà, R. Cela, G. Pereira, R. Barreto, X Ariza, M. Poca, J. Sánchez, G. Soriano, C. Alessandria, M. Guevara, J. Fernández, V. Arroyo, P. Ginès. Terlipressin and albumin improves systemic hemodynamics and kidney function in patients with type-1 hepatorenal syndrome associated whith active infections. Preliminary results of a prospective study. Monothematic Conference: Bacterial Infections in Cirrhosis - European Association for the Study of the Liver. Barcelona, Spain 2013

-E. Rodríguez, G. Pereira, M. Guevara, C. Fagundes, E. Sola, R. Barreto, M. Pavesi, V. Arroyo, P. Gines. Terlipressin and albumin for type-2 hepatorenal syndrome. Is it justified? Journal of Hepatology, Volume 56, Supplement 2, April 2012, Page S268. 47th Annual Meeting of the European Association for the Study of the Liver. Barcelona, Spain 2012.

2016 Premio Extraordinario de Doctorado. Universidad de Barcelona, Cataluña, España.
Tesis Doctoral: Insuficiencia renal en la cirrosis: Evaluación de nuevas clasificaciones pronósticas y tratamiento del síndrome hepatorrenal tipo asociado a sepsis.